Viruses That Mimic Human Proteins May Be More Common than Previously Thought

A screen of human-infecting viruses identified extensive examples of viral proteins that resembled human sequences, which could trigger autoimmune diseases like multiple sclerosis.

Written byShelby Bradford, PhD
| 4 min read
3D illustration of a blue virus (center) surrounded by magenta antibodies. More blue viruses are in the background.
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Distinguishing between self and non-self is a critical ability of the immune system. Some pathogens have evolved proteins that resemble those of their host, a mechanism called molecular mimicry, in an attempt to evade this surveillance system. However, immune training isn’t perfect, so host cells that recognize self-proteins occasionally slip into the milieu. Their presence doesn’t immediately raise any alarms, but if a pathogen with this same mimicked protein invades the body, it can trigger an immune response against the same sequence on the body’s own cells.

Previous work on molecular mimicry focused on the 3D structure of proteins, which is important for antibody-mediated immune recognition, but T cells typically recognize short, linear peptide sequences.1 Studies of mimicry in these short sequences often focus on a subset of viruses or suspected proteins.2,3 Now, researchers have performed a more comprehensive analysis, screening more than 100 human-infecting viruses for mimicry in short, linear peptide sequences.4 They demonstrated that this phenomenon is widespread across the virome. These findings, published in Nature Communications, could help researchers explore novel autoimmune triggers and potential interventions.

Esther Melamed, a physician scientist and neuroimmunologist at the University of Texas at Austin, and her group study how molecular mimicry impacts the development of autoimmune diseases. One in particular that her group is interested in is multiple sclerosis (MS), which has a strong association with Epstein Barr virus (EBV).5 Melamed said that her team was interested in exploring the contribution of other viruses.

When the COVID-19 pandemic forced their group to work from home, it introduced a perfect opportunity to explore this question since these sequences are available online. Cole Maguire, a neuroscience graduate student in Melamed’s group, first screened the SARS-CoV-2 virus for molecular mimicry. “Once we had it working, we're like, ‘Well, what if we just run it for every virus that we can’,” he said.

“We don't necessarily know why viruses gain [mimicry] and what advantages they have from gaining it,” Maguire explained. “This paper kind of takes the first step at looking at that, which might be useful in predicting future mutations.”

Using consensus sequences from 134 human-infecting viruses and the annotated human genome, the team looked for viral mimicry to linear sequences of eight, 12, or 18 amino acid residues that had no more than three mismatches in these epitopes. They found that viruses from the same family shared mimicked epitopes and that viruses that cause chronic infections demonstrated more mimicry compared to viruses that cause acute infections. Two families, Herpesviridae and Poxviridae, which include viruses like herpes simplex virus 1 and Mpox, demonstrated some of the highest rates of molecular mimicry.

“Even if you look at other autoimmune diseases [beyond MS], they're really associated with a variety of herpes viruses. So, seeing this trend at a family level was interesting because it might point to one reason why herpes viruses often associate with autoimmunity,” Maguire said.

“We wanted to really look at the biological effects and try to figure out how molecular mimicry fits into the human body as a whole,” Melamed said. To do this, the team analyzed the pathways that these mimicked proteins came from and found that many were involved in cellular replication and inflammation, but that there wasn’t a preference for a specific cell or tissue type.

Continue reading below...

Like this story? Sign up for FREE Immunology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Then, they investigated which chromosomes encoded the mimicked proteins. “One of the most interesting things to us was that, when we looked at chromosomes across the genome, viruses tended to avoid mimicking proteins encoded on the Y chromosome,” Melamed said, adding that this finding may indicate evolutionary pressure on the virus to mimic more universal proteins.

Because T cell immune training against self-proteins occurs in the thymus, the team compared the genes of the viral-mimicked proteins to those sequences that are expressed by thymic cells. They observed a large overlap of viral-mimicked sequences and those of thymic genes.

Finally, although MS has traditionally been characterized as a T cell mediated disorder, B cells have recently been shown to contribute to the autoimmune condition.6 The team explored the prevalence of MS autoantibodies targeting peptide sequences that are mimicked by EBV. They showed that the majority of the most common MS autoantibodies included an eight-residue sequence that matched an EBV sequence. “So, for the antibodies that do exist, EBV actually plays a big role in contributing to the generation of those antibodies,” Melamed said.

Ana Beatriz DePaula-Silva, an immunologist at the University of Utah who studies how viral infections contribute to neurological disorders and who was not involved with the study, said that it will be important to follow up this work with functional studies to determine if all of the mimicked sequences play a role in autoimmune disease development. However, she said that it was interesting to see the extent of mimicry in viruses. “It brings a lot to the field,” she said.

“I think the scale of what we found was that there are so many chronic viruses that can cause molecular mimicry really suggests that there's a larger problem at hand that we don't really think about when we see patients clinically with autoimmune diseases,” Melamed said.

Related Topics

Meet the Author

  • Shelby Bradford, PhD

    Shelby is an Assistant Editor at The Scientist. She earned her PhD in immunology and microbial pathogenesis from West Virginia University, where she studied neonatal responses to vaccination. She completed an AAAS Mass Media Fellowship at StateImpact Pennsylvania, and her writing has also appeared in Massive Science. Shelby participated in the 2023 flagship ComSciCon and volunteered with science outreach programs and Carnegie Science Center during graduate school. 

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control